Hydrochloric Acid → N1-({3-[(3-{[(5-Chloro-2-thienyl)sulfonyl]amino}-4-hydroxy-1H-indazol-1-yl)methyl]phenyl}methyl)-N2-methyl-D-alaninamide formic acid salt

HRID 1874721

반응식

HRID 1874721 반응식
N1(OC(N(C)C)=[N+](C)C)C2N=CC=CC=2N=N1.F[P-](F)(F)(F)(F)F.[C:25]([N:32]([CH3:38])[C@@H:33]([C:35]([OH:37])=O)[CH3:34])([O:27]C(C)(C)C)=[O:26].C(N(CC)C(C)C)(C)C.C(O)=O.[NH2:51][CH2:52][C:53]1[CH:54]=[C:55]([CH2:59][N:60]2[C:68]3[C:63](=[C:64]([OH:69])[CH:65]=[CH:66][CH:67]=3)[C:62]([NH:70][S:71]([C:74]3[S:75][C:76]([Cl:79])=[CH:77][CH:78]=3)(=[O:73])=[O:72])=[N:61]2)[CH:56]=[CH:57][CH:58]=1.Cl>CN(C=O)C.O1CCOCC1.CO.CO.CS(C)=O>[CH:25]([OH:27])=[O:26].[Cl:79][C:76]1[S:75][C:74]([S:71]([NH:70][C:62]2[C:63]3[C:68](=[CH:67][CH:66]=[CH:65][C:64]=3[OH:69])[N:60]([CH2:59][C:55]3[CH:54]=[C:53]([CH2:52][NH:51][C:35](=[O:37])[C@@H:33]([CH3:34])[NH:32][CH3:38])[CH:58]=[CH:57][CH:56]=3)[N:61]=2)(=[O:72])=[O:73])=[CH:78][CH:77]=1

참가 물질

10

실험 절차

To a solution of O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorophosphate (39.7 mg, 0.064 mmol) in anhydrous DMF (1 mL) was added at room temperature N-Boc-N-methyl-D-alanine (11.91 mg, 0.059 mmol), followed by N,N-diisopropylethylamine (0.0306 mL, 0.176 mmol) and finally a solution of N-(1-{[3-(aminomethyl)phenyl]methyl}-4-hydroxy-1H-indazol-3-yl)-5-chloro-2-thiophenesulfonamide formate salt (for a preparation see Intermediate 15) (29 mg, 0.059 mmol) in anhydrous DMF (1 mL). The reaction mixture was stirred at room temperature for 1 hour and then was partitioned between saturated aqueous sodium hydrogen carbonate solution and ethyl acetate. The organic layer was separated, washed with brine-water (1:1), passed through a hydrophobic frit, and evaporated in-vacuo to yield a colourless oil. LCMS (System B) RT=3.01 min, ES+ve m/z 634/636 (M+H)+ for desired BOC protected product. This product was suspended in a solution of hydrogen chloride in 1,4-dioxane (4M, 0.5 mL) and methanol was added until the reaction was in solution. The mixture was stirred at room temperature for 18 hours and then evaporated in-vacuo to yield a colourless oil. The residual oil was dissolved in MeOH-DMSO (0.5 mL) and purified by MDAP) on OA MDAP on Sunfire C18 column, eluting with solvents A/B (A: 0.1% v/v solution of formic acid in water, B: 0.1% v/v solution of formic acid in acetonitrile) (25 min run). The appropriate fractions were combined and evaporated in-vacuo to yield the title compound as a colourless oil (15 mg, 44%). LCMS (System B) RT=1.63 min, ES+ve m/z 534/536 (M+H)+

후처리

  1. customwas partitioned between saturated aqueous sodium hydrogen carbonate solution and ethyl acetate
  2. customThe organic layer was separated
  3. washwashed with brine-water (1:1)
  4. customevaporated in-vacuo
  5. customto yield a colourless oil
  6. additionwas added until the reaction
  7. stirringThe mixture was stirred at room temperature for 18 hours
  8. customevaporated in-vacuo
  9. customto yield a colourless oil
  10. custompurified by MDAP) on OA MDAP on Sunfire C18 column
  11. washeluting with solvents A/B (A: 0.1% v/v solution of formic acid in water, B
  12. custom(25 min run)
  13. customevaporated in-vacuo

출처 및 근거

ORD 기록
ord-e3d2f54b2c4c48debb82d085d1f53ef7
출처 데이터셋
uspto-grants-2012_11
특허 번호
US08304446B2

연결된 노트

불러오는 중…